Medtronic DTM spinal cord stimulator shows success in relieving back pain

Medtronic has released positive 12-month results from a clinical trial comparing its DTM spinal cord stimulation system to conventional spinal cord stimulation therapy with its Intellis system for the treatment of back pain.

Advertisement

Four things to know:

1. At 12 months, 84 percent of patients treated with the DTM system reported at least 50 percent pain relief, compared to 51 percent of patients treated with conventional spinal cord stimulation.

2. Sixty-nine percent of patients said they favored DTM spinal cord stimulation.

3. Pain relief was calculated by the visual analog scale, which recognizes 50 percent pain relief as a therapy’s standard for success.

4. Most DTM spinal cord stimulation patients in the study passed the 50 percent pain relief mark, with 70 percent noting significant relief at 12 months.

Click here for further details on the study.

More articles on devices:
A simple solution to the health insurance marketplace: Authorize interstate competition
Where orthopedic PE partnerships stand in 2020
Facet joint replacement, stem cells & AR: 9 surgeons discuss new technologies

Advertisement

Next Up in Spinal Tech

  • Medtech company Stryker reported sales increases across multiple portfolios in the third quarter, according to financial results posted Oct. 30.…

  • Here are four companies earning FDA clearance for spine technology this month: 1. Elevation Spine’s Saber-C earned FDA clearance for…

Advertisement

Comments are closed.